43 results
424B5
TCRX
Tscan Therapeutics Inc
17 Apr 24
Prospectus supplement for primary offering
9:58pm
in the assessment of our internal control over financial reporting.
We may take advantage of these exemptions until the fifth anniversary of our initial public
424B5
TCRX
Tscan Therapeutics Inc
16 Apr 24
Prospectus supplement for primary offering
5:21pm
parachute arrangements not previously approved; and
an exemption from the auditor attestation requirement in the assessment of our internal control
424B5
2nl 8k8rzjyrq
26 May 23
Prospectus supplement for primary offering
8:12pm
424B5
ckq dt7ofdxh
25 May 23
Prospectus supplement for primary offering
4:59pm
8-K
EX-99.1
2ydgxe0e vx
17 May 23
Poster highlights Phase 1 results following treatment with TSC-100 and TSC-101 after hematopoietic cell transplantation
8:15am
8-K
EX-1.1
v5jv3kggrd29tt9x
16 May 23
Other Events
5:21pm
424B5
jgfpi756drkjnpkts6h6
16 May 23
Prospectus supplement for primary offering
5:19pm
S-3
EX-4.4
46384a 17kdkwq2h
9 Nov 22
Shelf registration
7:53am